CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01911 CR HOLDINGS

Market Closed 10-23 16:08:08

3.635

+0.255

+7.54%

High3.640	Low3.290	Vol412.40K
Open3.380	D1 Closing3.380	Amplitude10.36%
Mkt Cap2.08B	Tradable Cap2.08B	Total Shares573.00M
T/O1.45M	T/O Rate0.07%	Tradable Shares573.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01911","market":"HK","secType":"STK","nameCN":"CR HOLDINGS","latestPrice":3.635,"timestamp":1792742888074,"preClose":3.38,"halted":0,"volume":412400,"delay":0,"changeRate":0.07544378698224849,"floatShares":573000000,"shares":573000000,"eps":0.19,"marketStatus":"Market Closed","change":0.255,"latestTime":"10-23 16:08:08","open":3.38,"high":3.64,"low":3.29,"amount":1453272,"amplitude":0.10355,"askPrice":3.635,"askSize":100,"bidPrice":3.5,"bidSize":42200,"shortable":0,"etf":0,"ttmEps":0.154,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":7,"adr":0,"listingDate":1537977600000,"exchange":"SEHK","adjPreClose":3.38,"openAndCloseTimeList":[[1792719000000,1792728000000],[1792731600000,1792742400000]],"volumeRatio":1.3975870953092557,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01911/tweets","defaultTab":"tweets","newsList":[{"id":"2677287949","title":"Innovent's Arcotatug Tavatecan Meets Survival Endpoints in Phase 3 Gastric Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2677287949","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677287949?lang=en_us&edition=fundamental","pubTime":"2026-10-23 18:10","pubTimestamp":1792750257,"startTime":"0","endTime":"0","summary":"Innovent's Arcotatug Tavatecan Meets Survival Endpoints in Phase 3 Gastric Cancer TrialInnovent Biologics announced Oct. 23, 2026, that arcotatug tavatecan met both primary survival endpoints in the P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nNDLWnktX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0455707207.USD","LU1188198961.HKD","BK1161","BK1589","LU2328871848.SGD","LU1969619763.USD","LU2097828631.EUR","LU2242644610.SGD","LU0326950275.SGD","LU1831875114.USD","LU0244354667.USD","HK0000165453.HKD","LU2097828474.EUR","LU2097828557.USD","LU2488822045.USD","LU0607220059.USD","BK1583","KURE","01801","LU2097828805.USD","LU0463099449.HKD","LU0502904849.HKD","BK1147","LU2097828714.EUR","LU0149534421.HKD","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169598885","title":"CR Holdings’ Investee Billu Electronics Lists on NEEQ with CR Securities as Lead Sponsor","url":"https://stock-news.laohu8.com/highlight/detail?id=1169598885","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169598885?lang=en_us&edition=fundamental","pubTime":"2026-10-23 17:01","pubTimestamp":1792746101,"startTime":"0","endTime":"0","summary":"On 23 October 2026, CR Holdings (China Renaissance Holdings Limited) announced that Shanghai Billu Electronics Co., Ltd. has commenced public trading on China’s National Equities Exchange and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677491642","title":"Asian Penny Stocks With Market Caps Up To US$300M","url":"https://stock-news.laohu8.com/highlight/detail?id=2677491642","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677491642?lang=en_us&edition=fundamental","pubTime":"2026-10-21 12:04","pubTimestamp":1792555487,"startTime":"0","endTime":"0","summary":"Amidst global market fluctuations driven by AI spending concerns and inflationary pressures, the Asian markets have been navigating a complex landscape. In this context, penny stocks—often smaller or less-established companies—remain an intriguing area for investors seeking potential growth opportunities. While the term \"penny stock\" may seem outdated, these stocks can still represent value when backed by solid financials and growth prospects. This article highlights three such Asian penny...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6033000-choice1-card/1788938511465"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-383/tian-an-medicare-shares/news/asian-penny-stocks-with-market-caps-up-to-us300m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-383/tian-an-medicare-shares/news/asian-penny-stocks-with-market-caps-up-to-us300m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK6030","01911","LVR.SI","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671914282","title":"Innovent Says Trispecific Antibody Ibi3003 Posts 84.6% ORR at Phase 1 RP2D in Relapsed/refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671914282","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671914282?lang=en_us&edition=fundamental","pubTime":"2026-09-29 15:46","pubTimestamp":1790667978,"startTime":"0","endTime":"0","summary":"Innovent says trispecific antibody IBI3003 posts 84.6% ORR at Phase 1 RP2D in relapsed/refractory multiple myelomaInnovent disclosed updated Phase 1 results for IBI3003 in relapsed or refractory multi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDLTnt3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","HK0000165453.HKD","LU0326950275.SGD","LU0149534421.HKD","LU2242644610.SGD","BK1589","01911","LU1969619763.USD","LU1831875114.USD","LU2097828474.EUR","LU0244354667.USD","BK1161","LU0455707207.USD","KURE","01801","LU0463099449.HKD","LU0607220059.USD","LU2097828714.EUR","LU0502904849.HKD","BK1147","LU2488822045.USD","LU1188198961.HKD","LU2097828557.USD","BK1583","LU2097828805.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143653011","title":"CR HOLDINGS Publishes Interim Report and Confirms Full Transition to Electronic Corporate Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1143653011","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143653011?lang=en_us&edition=fundamental","pubTime":"2026-09-28 09:20","pubTimestamp":1790558436,"startTime":"0","endTime":"0","summary":"China Renaissance Holdings Limited (CR HOLDINGS) released its latest Interim Report on 28 September 2026. The English and Chinese versions are now accessible on both the HKEX website...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402351","title":"Innovent Expands Phase 3 MarsLight-11 Trial of Ibi363/tak-928 to Include Non-Squamous NSCLC Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402351","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402351?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:00","pubTimestamp":1790553625,"startTime":"0","endTime":"0","summary":"Innovent expands Phase 3 MarsLight-11 trial of IBI363/TAK-928 to include non-squamous NSCLC patientsInnovent Biologics expanded its global Phase 3 MarsLight-11 trial of IBI363/TAK-928 to include non-s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8bvkF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","LU2097828631.EUR","01801","LU0607220059.USD","LU0326950275.SGD","HK0000165453.HKD","01911","LU0455707207.USD","LU2328871848.SGD","BK1147","LU1831875114.USD","LU0463099449.HKD","LU0502904849.HKD","LU2097828474.EUR","LU0149534421.HKD","LU1969619763.USD","LU2097828714.EUR","LU0244354667.USD","LU2488822045.USD","LU2097828557.USD","BK1583","BK1161","BK1589","KURE","LU1188198961.HKD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669092751","title":"Innovent to Present Phase 3 Interim Data for Cldn18.2 ADC Ibi343 in Third-Line Gastric Cancer at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669092751","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669092751?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:49","pubTimestamp":1790153370,"startTime":"0","endTime":"0","summary":"Innovent to present phase 3 interim data for CLDN18.2 ADC IBI343 in third-line gastric cancer at ESMO 2026Innovent Biologics scheduled new clinical readouts for its next-generation immuno-oncology and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDLc9g4S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","LU2097828631.EUR","01801","LU0607220059.USD","LU0326950275.SGD","HK0000165453.HKD","01911","LU0455707207.USD","LU2328871848.SGD","BK1147","LU1831875114.USD","LU0463099449.HKD","LU0502904849.HKD","LU2097828474.EUR","LU0149534421.HKD","LU1969619763.USD","LU2097828714.EUR","LU0244354667.USD","LU2488822045.USD","LU2097828557.USD","BK1583","BK1161","BK1589","KURE","LU1188198961.HKD","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107498623","title":"Hong Kong Stock Market News Roundup: Insilico Medicine Secures Multi-Million-Dollar AI Collaboration Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1107498623","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107498623?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:10","pubTimestamp":1790039423,"startTime":"0","endTime":"0","summary":"Key Developments: Huanchuang Technology (06802) plans a global offering of 11.5888 million shares, with listing expected on September 30. Nazhen Technology (09856) saw its Hong Kong public offering...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","BK1589","BK4585","VTHR","BK1155","BK1526","BK1586","KCAI","00354","LU2213484517.USD","CHAT","01911","03696","BK4588","BK1518","BK1161","ARTY","AIPO","BK1147","02595","06936","QTOC","BK1151","BK1141","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669415300","title":"China Renaissance's Unit Advises AI Company on Series B+, Series C Fundraising","url":"https://stock-news.laohu8.com/highlight/detail?id=2669415300","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669415300?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:35","pubTimestamp":1789976141,"startTime":"0","endTime":"0","summary":"China Renaissance's (HKG:1911) unit CRP-Fanya Investment Consultants (Beijing) assisted Beijing SiliconFlow Technology in raising funds, a Monday bourse filing showed.Beijing SiliconFlow Technology ha","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIX","VTHR","QTOC","BK1147","CHAT","ARTY","01911","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122758333","title":"CR Holdings Unit Concludes Series B+ Second Tranche and Series C Funding for AI Token Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=1122758333","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122758333?lang=en_us&edition=fundamental","pubTime":"2026-09-21 12:12","pubTimestamp":1789963924,"startTime":"0","endTime":"0","summary":"CR Holdings (01911) has announced that its wholly-owned subsidiary, Huaxing Pan-Asia Investment Advisory (Beijing) Co., Ltd., acting as the exclusive financial advisor, has successfully facilitated...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","AGIX","VTHR","CHAT","BK1147","01911","AIPO","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184266083","title":"Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=1184266083","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184266083?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430067,"startTime":"0","endTime":"0","summary":"The 2026 World Conference on Lung Cancer (WCLC) taking place in Seoul from September 12-15 has become a major catalyst for Chinese innovative drug developers, with a record number of clinical data...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","LU1226287792.SGD","LU2039709279.SGD","IBBQ","LU1813983027.USD","LU0880133367.SGD","CDMO","LU1226288170.HKD","BK1191","LU0140636845.USD","LU0501845795.SGD","IE00BZ08YS42.EUR","BK4585","HK0000165453.HKD","LU0315179316.USD","06871","KURE","LU0067412154.USD","01093","LU0072913022.USD","BK1539","02889","IE0008369823.USD","IE00B543WZ88.USD","LU1951186391.HKD","LU1152091168.USD","SG9999004220.SGD","BK1515","159992","02238","IE00B5MMRT66.SGD","BK1183","BK1144","LU0326950275.SGD","LU1807302812.USD","MEDX","BK1161","IE00B031HY20.USD","VXUS","LU1226287875.USD","BK4139","IE0008368742.USD","06978","LU1960683339.HKD","BK1574","BK1521","LU1226288253.USD","BK1119","IE00BZ08YR35.GBP","LU1226287529.USD","LU1993786604.SGD","BK4588","LNGR","KCAI","LU1152091754.HKD","LU1328277881.USD","BK1147","LU0314109678.HKD","01911","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133429611","title":"CR Holdings Facilitates Successful Series B Funding Round for AlphaPai, an AI Application Focused on Financial Scenarios","url":"https://stock-news.laohu8.com/highlight/detail?id=1133429611","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133429611?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:36","pubTimestamp":1789374995,"startTime":"0","endTime":"0","summary":"CR Holdings (01911) has announced that its indirect wholly-owned subsidiary, CR PanAsia Investment Advisory (Beijing) Co., Ltd., served as the exclusive financial advisor for the latest Series B...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK4585","BK1147","AIQ","159940","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170094537","title":"CR Holdings Reports Zero Share Movements in August; Public Float Remains Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1170094537","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170094537?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:43","pubTimestamp":1788425034,"startTime":"0","endTime":"0","summary":"China Renaissance Holdings Limited (“CR Holdings”, HKEX: 01911) released its Monthly Return for August 2026, confirming that no changes occurred in either authorised or issued share capital during...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857975","title":"Innovent Biologics Grants 583,731 Restricted Shares Under 2024 Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857975","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664857975?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:49","pubTimestamp":1788274144,"startTime":"0","endTime":"0","summary":"Innovent Biologics grants 583,731 restricted shares under 2024 share schemeInnovent Biologics granted 59,757 share options, exercisable at HK$ 105.76 per share, with a 10-year exercise period.It also ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8nZgF0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0244354667.USD","BK1583","01911","HK0000165453.HKD","KURE","LU0502904849.HKD","LU2242644610.SGD","LU0463099449.HKD","LU2097828631.EUR","LU2097828557.USD","BK1161","LU2097828714.EUR","LU1969619763.USD","LU1188198961.HKD","LU2328871848.SGD","LU0326950275.SGD","LU2097828474.EUR","BK1147","01801","LU0455707207.USD","BK1589","LU2097828805.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859365","title":"Innovent Biologics Files List of Board, Board Committee Members with Disclosure Duties","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859365","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859365?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:17","pubTimestamp":1788265039,"startTime":"0","endTime":"0","summary":"Innovent Biologics files list of board, board committee members with disclosure dutiesInnovent updated its board and committee roster as of Sept. 1, 2026, naming Yu Dechao as chairman, chief executive","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL3jJnGX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0455707207.USD","HK0000165453.HKD","LU2097828805.USD","KURE","LU0326950275.SGD","LU2097828631.EUR","01801","LU0463099449.HKD","LU2097828474.EUR","01911","LU2097828714.EUR","BK1589","BK1161","LU2097828557.USD","LU2488822045.USD","BK1583","LU2242644610.SGD","LU1969619763.USD","LU2328871848.SGD","LU0244354667.USD","LU0502904849.HKD","BK1147","LU1188198961.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086799","title":"Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662086799?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:51","pubTimestamp":1787842274,"startTime":"0","endTime":"0","summary":"Innovent Biologics files HKEX next-day disclosure return, issues 182,021 new sharesInnovent filed a next-day disclosure return on Aug. 27, 2026 for share issuances from option exercises.Issued 182,021","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL82CCyd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0455707207.USD","LU1188198961.HKD","BK1161","BK1589","LU2328871848.SGD","LU1969619763.USD","LU2097828631.EUR","LU2242644610.SGD","LU0326950275.SGD","LU0244354667.USD","HK0000165453.HKD","LU2097828474.EUR","LU2097828557.USD","LU2488822045.USD","BK1583","KURE","01801","LU2097828805.USD","LU0463099449.HKD","LU0502904849.HKD","BK1147","LU2097828714.EUR","01911"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662968777","title":"China Renaissance H1 Revenue Falls 3% as Management Fees Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2662968777","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662968777?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:23","pubTimestamp":1787822611,"startTime":"0","endTime":"0","summary":"China Renaissance H1 revenue falls 3% as management fees dropOverviewChina investment bank's H1 revenue fell 3% yr/yr as management fees declinedNet income attributable to owners dropped to RMB40.5 ml","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0276","BK4531","BK1147","BK0201","BK4135","601375","NOAH","01911","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139707721","title":"CR Holdings Posts 37.7% Drop in Mid-Year Profit to 40.47 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1139707721","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139707721?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:21","pubTimestamp":1787822463,"startTime":"0","endTime":"0","summary":"CR Holdings (01911) has unveiled its interim results for 2026, with total revenue coming in at approximately 412 million yuan, a year-on-year decline of 3.05%. Meanwhile, the combined figure for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662077221","title":"China Renaissance - Board Does not Recommend Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2662077221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662077221?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:11","pubTimestamp":1787821912,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O0QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662243772","title":"China Renaissance Holdings H1 Net Income Attributable RMB 40.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662243772","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662243772?lang=en_us&edition=fundamental","pubTime":"2026-08-27 17:11","pubTimestamp":1787821864,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nPLXM6BW7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01911","BK1147"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinarenaissance.com","stockEarnings":[{"period":"1week","weight":0.1116},{"period":"1month","weight":-0.0095},{"period":"3month","weight":0.1613},{"period":"6month","weight":0.0154},{"period":"1year","weight":-0.3982},{"period":"ytd","weight":-0.1199}],"compareEarnings":[{"period":"1week","weight":-0.0452},{"period":"1month","weight":-0.0701},{"period":"3month","weight":-0.0749},{"period":"6month","weight":-0.111},{"period":"1year","weight":-0.1107},{"period":"ytd","weight":-0.099}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Renaissance Holdings Ltd is a holding company that is primarily engaged in providing investment banking and investment management services. The Company operates in four segments. Investment Banking segment provides early to late stage financial advisory and mergers and acquisitions advisory services, equity underwriting, sales, trading, brokerage, research services and structured financial services. Investment Management segment provides fund and asset management and manages its own investments in funds. China Renaissance (CR) Securities segment provides investment banking and asset management business. Others segment mainly includes wealth management business and investment and management of own funds.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.099096},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.014364},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.054298},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.054187},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.049653},{"month":6,"riseRate":0.833333,"avgChangeRate":0.099698},{"month":7,"riseRate":0.5,"avgChangeRate":0.05207},{"month":8,"riseRate":0.666667,"avgChangeRate":0.094668},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.10188},{"month":10,"riseRate":0.125,"avgChangeRate":-0.110799},{"month":11,"riseRate":0.285714,"avgChangeRate":0.027229},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.035994}],"exchange":"SEHK","name":"CR HOLDINGS","nameEN":"CR HOLDINGS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CR HOLDINGS(01911) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CR HOLDINGS,01911,CR HOLDINGS股票,CR HOLDINGS股票老虎,CR HOLDINGS股票老虎国际,CR HOLDINGS行情,CR HOLDINGS股票行情,CR HOLDINGS股价,CR HOLDINGS股市,CR HOLDINGS股票价格,CR HOLDINGS股票交易,CR HOLDINGS股票购买,CR HOLDINGS股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CR HOLDINGS(01911),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CR HOLDINGS(01911) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}